Share
North American Drug Delivery Technologies Market: By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Transmucosal Drug Delivery), By Type (Advanced, Conventional), By Application (Disease Treatment, Research/Academic Purposes), By End User (Hospitals, Home Care Settings, Ambulatory Surgical Centers/Clinics, Others), And Region – Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
North American Drug Delivery Technologies Market to surpass USD 1080.8 billion by 2032 from USD 423.5 billion in 2021 at a CAGR of 8.9% in the coming years, i.e., 2022-32
Drug delivery systems can be defined as the technologies that transfer drugs throughout or in the body. The delivery mechanism like a pill swallowed by patients or an injection-based vaccine is one such technology. Medicine packaging like a nanoparticle or a micelle, which prevents the drug from degrading and allows it to travel the specific body part, is another term for drug delivery systems. Earlier, doctors tried to administer therapies to the body parts that were directly affected by the sickness. Some medications can be administered locally, which minimizes side effects and drug toxicity while maximizing the effectiveness of a treatment, as opposed to systemically, which has an impact on the entire body.
North American Drug Delivery Technologies Market to surpass USD 1080.8 billion by 2032 from USD 423.5 billion in 2021 at a CAGR of 8.9% in the coming years, i.e., 2022-32. Recently, a number of drug delivery systems have become more noteworthy in the North American market. The most commonly accepted method is controlled release, and it comprises dry powder inhalers, orodispersible tablets (ODT), needle-free injectors, transdermal patches, buccal transmucosal tablets, and auto and pen injectors. Drug distribution through implanted devices is also becoming more popular. These factors are expected to drive the North American Drug Delivery Technologies Market over the estimated period.
North American Drug Delivery Technologies Market is categorized on the basis of Route of Administration into Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Transmucosal Drug Delivery. The Oral Drug Delivery system is predicted to hold a leading market share due to the strong acceptance of oral drug delivery routes of administration by patients as a very practical and risk-free method of medication administration.
North American Drug Delivery Technologies Market is categorized on the basis of Application into Disease Treatment and Research/Academic Purposes. The Disease Treatment segment is anticipated to have a sizeable market share since medication delivery is frequently used to treat chronic and other widespread disorders. Also, the number of patients suffering from chronic diseases is rising on a global scale, which ultimately impacts the segment growth.
Growing Prevalence of Several Chronic Diseases and Innovations in the Drug Delivery Systems
In past years, the North American region has witnessed a significant rise in the prevalence of several illnesses and medical conditions, including cancer, respiratory diseases, cancer, diabetes, cardiovascular diseases, and neurological disorders. The demand for the drug delivery market in the region is anticipated to rise as a result of the persistent rise in the prevalence of common chronic disorders. Transdermal patches, injectable and pulmonary drug delivery systems, and other recent advancements and improvements in the drug delivery system are all contributing to the growth of the North American Drug Delivery Technologies Market over the projection period.
Progressing Biologics Domain and Growing Competition due to the Production of Branded and Generic Drugs
The pharmaceutical market's fastest-growing sector is biologics. The market for drug delivery in the North America will grow on the back of the growth of biologics. With numerous new competitors entering the market, the development and production of both branded and generic medications are becoming more and more competitive. The market will become more competitive as a result.
Strict Regulations by the FDA for Approval of Drugs and Medical Devices
The development of the market during the forecast period may be hampered by the strict requirements for the approval of pharmaceuticals and medical devices. The FDA has a five-step approval process and it is mandatory to obtain FDA’s permission before selling any medication on the North American region. The rules are highly rigorous, which is limiting the growth of the North American Drug Delivery Technologies Market throughout the anticipated period.
(Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
North American Drug Delivery Technologies Market is segmented based on regional analysis into two regions: United States and Canada. Throughout the projected period, the U.S. is anticipated to maintain its market dominance. The U.S. has a significant market share in North America, which is primarily due to factors like the rising cases of chronic diseases, the aging population's rapid growth, the rising number of regulatory approvals, and the biologics market, technological advancements, and new product launches.
The COVID-19 pandemic caused a rise in the medicine delivery market in North America as the region's need for healthcare surged dramatically due to the disease spread. The North American Drug Delivery Technologies Market has grown due to ineffective healthcare infrastructure, a lack of pharmaceuticals, and other factors. Moreover, the pandemic made the FDA approval process somewhat simpler, which contributed to the growth of the industry.
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
USD 423.5 billion |
|
Revenue Forecast in 2032 |
USD 1080.8 billion |
|
Growth Rate |
CAGR of 8.9% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Quantitative Units |
Revenue in USD billion and CAGR from 2022 to 2032 |
|
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments Covered |
Route of Administration, Type, Application, End User, and Region |
|
Regional Scope |
United States and Canada |
|
Key Companies Profiled |
Johnson & Johnson Inc., Medtronic PLC, 3M Company, Pfizer Inc, Becton, Dickinson and Company, Merck & Co. Inc., Boston Scientific Corporation, Cipla Inc., Gerresheimer AG, West Pharmaceutical Services Inc., and Other Prominent Players. |
The North American Drug Delivery Technologies Market size was estimated at USD 423.5 billion in 2021 and is expected to reach USD 1080.8 billion in 2032.
Drug delivery systems can be defined as the technologies that transfer drugs throughout or in the body. The delivery mechanism like a pill swallowed by patients or an injection-based vaccine, is one such technology.
The Oral Drug Delivery and Disease Treatment segments accounted for the larger share of the North American Drug Delivery Technologies Market.
Key players in the North American Drug Delivery Technologies Market are Johnson & Johnson Inc., Medtronic PLC, 3M Company, Pfizer Inc, Becton, Dickinson and Company, Merck & Co. Inc., Boston Scientific Corporation, Cipla Inc., Gerresheimer AG, West Pharmaceutical Services Inc., and Other Prominent Players.
The major drivers of the North American Drug Delivery Technologies Market are the prevalence of common chronic disorders and recent advancements and improvements in the drug delivery system.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
